Skip to content
July 01, 2022

Equity.Guru

Investment information for the new generation

Today’s Idea

Last year Big Pharma unleashed 1,500 lobbyists to Washington, DC, who then cut cheques for $177 million to keep drug costs high. The lobbyists deserve bonuses. The average U.S….
Special Delivery $19.043M Market Capitalization Lexaria Bioscience Corp. (LEXX.Q) is a biotechnology company developing DehydraTECH™, the Company’s proprietary drug delivery technology. In addition to enhancing the speed and efficiency of…
It is no secret that we here at Equity Guru are big fans of Nomad Royalty (NSR.TO). Earlier this year, we covered why this royalty and streamer company deserves…
Futuristic Shock & Awe   As a kid, we all grew up fantasizing about the day we could finally immerse ourselves in a virtual world. Movies like Ready Player…
It would be an understatement to say that we are bullish uranium here at Equity Guru. We love uranium. Barring the whole idea of commodities and hard assets doing…
Long term. You have probably heard or read those two words more times than you can remember in the past few days. Stock markets are selling off hard, bond…
Stock markets are looking scary, but the debt markets are truly worrying. Before we get to the instability in debt, and what that means, let’s breakdown what is affecting…
In years past, gambling was considered to be something of a dubious past-time.  It was always connected with something socially negative, like degeneracy or illegal activities, and being recognized…
Why copper and why now? My readers know me as the commodity guy. My love for precious metals is not a secret. Just check out my gold vault on…
The more I hear about the metaverse the less I’m convinced that it’s going to be the great disruptive, revolutionary next-gen platform many companies are banking on. Instead, it’s…